Takeda CEO Christophe Weber faces opposition to board reelection

asia.nikkei.com/Business/Pharmaceuticals/Takeda-CEO-Christophe-Weber-faces-opposition-to-board-reelection

TOKYO -- U.S. proxy advisory firm Institutional Shareholder Services (ISS) is recommending shareholders vote against the reelection of Takeda Pharmaceuticals CEO Christophe Weber to the Japanese drugmaker's board, according to Takeda.
Takeda does not support the recommendation, and it is…

This story appeared on asia.nikkei.com, 2025-06-07 00:00:00.
The Entire Business World on a Single Page. Free to Use →